Total submissions: 8
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Prevention |
RCV000242568 | SCV000303538 | likely benign | not specified | criteria provided, single submitter | clinical testing | ||
Labcorp Genetics |
RCV001079761 | SCV000658975 | benign | Autosomal dominant polycystic kidney disease | 2025-01-29 | criteria provided, single submitter | clinical testing | |
Athena Diagnostics | RCV000712684 | SCV000843203 | benign | not provided | 2017-12-29 | criteria provided, single submitter | clinical testing | |
ARUP Laboratories, |
RCV000712684 | SCV000884377 | likely benign | not provided | 2017-09-14 | criteria provided, single submitter | clinical testing | The PKD2 c.570G>T; p.Ala190Ala variant (rs541702320) has not been reported in the medical literature, but is listed as likely neutral in the Mayo ADPKD database (see link). It is reported in ClinVar (Variation ID: 255795) and observed in the African population at an overall frequency of 2% (232/11682 alleles) in the Genome Aggregation Database. This is a synonymous variant in a nucleotide that is weakly conserved, and computational algorithms (Alamut v.2.11) predict no impact on splicing. Based on available information, this variant is considered likely benign. |
Illumina Laboratory Services, |
RCV001155350 | SCV001316774 | benign | Polycystic kidney disease 2 | 2017-04-28 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases was too high to be consistent with this variant causing disease. Therefore, this variant is classified as benign. |
Gene |
RCV000712684 | SCV001829257 | likely benign | not provided | 2020-11-20 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV001155350 | SCV002805022 | likely benign | Polycystic kidney disease 2 | 2021-07-23 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV000712684 | SCV005260193 | likely benign | not provided | criteria provided, single submitter | not provided |